Related Content
Search Google Scholar for:
|
|
Science 21 March 1997: Vol. 275. no. 5307, pp. 1755 - 1757 DOI: 10.1126/science.275.5307.1755
|
|
Policy Forum
Karen Rothenberg,
*
Barbara Fuller,
Mark Rothstein,
Troy Duster,
Mary Jo Ellis Kahn,
Rita Cunningham,
Beth Fine,
Kathy Hudson,
Mary-Claire King,
Patricia Murphy,
Gary Swergold,
Francis Collins
The use of genetic
information in the workplace poses societal risks that have an impact
on employment possibilities, health insurance, and privacy. Individuals
who might otherwise believe they can benefit from genetic testing may
decline it because of their fear of employment discrimination and lack
of privacy in the workplace. As a consequence, the future of research
on the benefits and risks of predictive genetic testing may also be
compromised. Thus, policy-makers need to evaluate legislative and
regulatory strategies to address these concerns. This paper analyzes
state and federal legislative approaches to genetic information in the workplace and concludes with a discussion of policy considerations and
recommendation.
The authors are members of the Committee on Genetic Information
and the Workplace of the National Action Plan on Breast Cancer (NAPBC)
and the National Institutes of Health-Department of Energy Working
Group on Ethical, Legal and Social Implications of Human Genome
Research (the ELSI Working Group). K. Rothenberg is director of the Law
and Health Care Program, University of Maryland School of Law, and
chair of the Committee on Genetic Information and the Workplace and is
a member of the NAPBC. B. Fuller is with the NAPBC. M. Rothstein is at
the Health Law and Policy Institute, University of Houston Law Center,
and a member of the NAPBC. T. Duster is at the Institute for the Study
of Social Change, University of California, Berkeley, and is chair of
the ELSI Working Group. M. J. Ellis Kahn is with the Virginia Breast
Cancer Foundation and is co-chair of the NAPBC Hereditary
Susceptibility Working Group. R. Cunningham is with the African
American Breast Cancer Alliance of Minnesota and is a member of the
NAPBC. B. Fine is at Northwestern University Medical School and is a
member of the ELSI Working Group. K. Hudson is at the National Human
Genome Research Institute, National Institutes of Health. M.-C. King is
with the Division of Medical Genetics, University of Washington, and is
a member of the NAPBC. P. Murphy is with OncorMed, Gaithersburg, MD,
and is a member of the NAPBC. G. Swergold is at the Center for
Biologics Evaluation and Research, U.S. Food and Drug Administration,
and is a member of the NAPBC. F. Collins is at the National Human
Genome Research Institute, National Institutes of Health, and is
co-chair of the NAPBC Hereditary Susceptibility Working Group.
*
To whom correspondence should be addressed at the Law and Health
Care Program, University of Maryland School of Law, 500 West Baltimore
Street, Baltimore, MD 21201, USA.
Volume 275, Number 5307,
Issue of 21 March 1997,
pp. 1755-1757
©1997 by The American Association for the Advancement of Science.
Read the Full Text
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
- Keeping Pace with the Times -- The Genetic Information Nondiscrimination Act of 2008.
- K. L. Hudson, M.K. Holohan, and F. S. Collins (2008)
N. Engl. J. Med.
358, 2661-2663
| Full Text »
| PDF »
- Currents in Contemporary Ethics..
- M. A. Rothstein (2008)
J. Law Med. Ethics
36, 174-178
| PDF »
- Genetic Screening and Disability Insurance: What Can We Learn From The Health Insurance Experience?.
- N. Kass and A. Medley (2007)
J. Law Med. Ethics
35, 66-73
| PDF »
- Ethical Issues in the Use of Genetic Information in the Workplace: A Review of Recent Developments.
- C. M.A. Geppert and L. W. Roberts (2007)
Focus
5, 444-450
| Abstract »
| Full Text »
| PDF »
- Banning Genetic Discrimination.
- H. T. Greely (2005)
N. Engl. J. Med.
353, 865-867
| Full Text »
| PDF »
- Genetic Testing and its Implications: Human Genetics Researchers Grapple with Ethical Issues.
- I. Rabino (2003)
Science Technology Human Values
28, 365-402
| Abstract »
| PDF »
- Chevron v Echazabal: Public Health Issues Raised by the "Threat-to-Self" Defense to Adverse Employment Actions.
- M. Barnes, K. A. Cleaveland, and P. S. Florencio (2003)
Am J Public Health
93, 536-540
| Abstract »
| Full Text »
| PDF »
- "Genetic Exceptionalism" in Medicine: Clarifying the Differences between Genetic and Nongenetic Tests.
- M. J. Green and J. R. Botkin (2003)
Ann Intern Med
138, 571-575
| Abstract »
| Full Text »
| PDF »
- BRCA1/2 Genetic Testing in the Community Setting.
- W. Y. Chen, J. E. Garber, S. Higham, K. A. Schneider, K. B. Davis, A. M. Deffenbaugh, T. S. Frank, R. S. Gelman, and F. P. Li (2002)
J. Clin. Oncol.
20, 4485-4492
| Abstract »
| Full Text »
| PDF »
- Public Attitudes About Genetic Testing For Alzheimer's Disease.
- P. J. Neumann, J. K. Hammitt, C. Mueller, H. M. Fillit, J. Hill, N. A. Tetteh, and K. S. Kosik (2001)
Health Aff.
20, 252-264
| Abstract »
| Full Text »
| PDF »
- Implications of the Human Genome Project for Medical Science.
- F. S. Collins and V. A. McKusick (2001)
JAMA
285, 540-544
| Abstract »
| Full Text »
| PDF »
- Human Tissue Research in the Genomic Era of Medicine: Balancing Individual and Societal Interests.
- T. T. Ashburn, S. K. Wilson, and B. I. Eisenstein (2000)
Arch Intern Med
160, 3377-3384
| Abstract »
| Full Text »
| PDF »
- A 40-Year-Old Woman With a Strong Family History of Breast Cancer.
- J. Garber (1999)
JAMA
282, 1953-1960
| Full Text »
| PDF »
- Functional Genomics: Clinical Effect and the Evolving Role of the Surgeon.
- A. Hernandez and B. M. Evers (1999)
Arch Surg
134, 1209-1215
| Abstract »
| Full Text »
| PDF »
- Medical and Societal Consequences of the Human Genome Project.
- F. S. Collins (1999)
N. Engl. J. Med.
341, 28-37
| Full Text »
| PDF »
- Cancer Control in Susceptible Groups: Opportunities and Challenges.
- F. P. Li (1999)
J. Clin. Oncol.
17, 719
| Abstract »
| Full Text »
| PDF »
- Hereditary Risk of Breast and Ovarian Carcinoma: The Role of the Oncologist.
- T. S. Frank (1998)
Oncologist
3, 403-412
| Abstract »
| Full Text »
- Public Health Surveillance for Hereditary Hemochromatosis.
- S. F. Wetterhall, M. E. Cogswell, and K. V. Kowdley (1998)
Ann Intern Med
129, 980-986
| Abstract »
| Full Text »
- Impact of Laboratory Molecular Diagnosis on Contemporary Diagnostic Criteria for Genetically Transmitted Cardiovascular Diseases: Hypertrophic Cardiomyopathy, Long-QT Syndrome, and Marfan Syndrome : A Statement for Healthcare Professionals From the Councils on Clinical Cardiology, Cardiovascular Disease in the Young, and Basic Science, American Heart Association.
- B. J. Maron, J. H. Moller, C. E. Seidman, G. M. Vincent, H. C. Dietz, A. J. Moss, J. A. Towbin, H. M. Sondheimer, R. E. Pyeritz, G. McGee, et al. (1998)
Circulation
98, 1460-1471
| Full Text »
| PDF »
- Frequency of Breast Cancer Attributable to BRCA1 in a Population-Based Series of American Women.
- B. Newman, H. Mu, L. M. Butler, R. C. Millikan, P. G. Moorman, and M.-C. King (1998)
JAMA
279, 915-921
| Abstract »
| Full Text »
| PDF »
- The new genetics: Genetic testing and public policy.
- N. A Holtzman and D. Shapiro (1998)
BMJ
316, 852-856
| Full Text »
- Genetic Testing for Cancer Risk.
- B. Ponder (1997)
Science
278, 1050-1054
| Abstract »
| Full Text »
- Predictive Genetic Testing: From Basic Research to Clinical Practice.
- N. A. Holtzman, P. D. Murphy, M. S. Watson, and P. A. Barr (1997)
Science
278, 602-605
| Abstract »
| Full Text »
E-Letters:
Read all E-Letters
- Untitled
- Kathleen Condon
- Science Online, 8 Oct 1999
[Full text]
- Response
- A. Brooks Irvine
- Science Online, 18 Oct 1999
[Full text]
- Genetic Research
- Alania Bogrin
- Science Online, 1 Nov 2000
[Full text]
|
|